Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models.
Petcherski A, Sharma M, Satta S, Daskou M, Vasilopoulos H, Hugo C, Ritou E, Dillon BJ, Fung E, Garcia G, Scafoglio C, Purkayastha A, Gomperts BN, Fishbein GA, Arumugaswami V, Liesa M, Shirihai OS, Kelesidis T.
Petcherski A, et al. Among authors: arumugaswami v.
bioRxiv [Preprint]. 2022 Jun 23:2022.02.22.481100. doi: 10.1101/2022.02.22.481100.
bioRxiv. 2022.
PMID: 35233569
Free PMC article.
Preprint.